U.S. investors cut their use of leverage in July, marking the first month since the onset of the pandemic that saw a reduction in the use of margin debt to buy securities like stocks, potentially a warning sign for markets buoyed by heavy use of borrowed money.
Every single Republican member of the House of Representatives has now signed a petition demanding that Nancy Pelosi allow a vote on a pro-life bill to stop infanticide.
Multinational telecommunications conglomerate Verizon has internal programs that train employees on anti-American sentiments and "anti-racism" agendas, according to a new report.
In the early days of any administration, there is a tendency for new presidents to blame their predecessors for problems they claim to have inherited — and there is a window during which the public is willing to accept such arguments. But for President Biden, the window on blaming Donald Trump has now closed. As Americans process the tragic news of double-digit deaths of U.S. service members in twin terrorist attacks in the midst of a botched withdrawal from Afghanistan, it will be hard for Biden to dodge responsibility.
Pfizer CEO Albert Bourla told Fox News the company has a system in place to turn around a variant-specific jab within 95 days in the likelihood a vaccine-resistant COVID strain emerges, but experts warn that strategy will backfire.
The House of Representatives’ Select Committee investigating the 6 January Capitol violence began its first hearing on 27 July in the wake of Republicans lawmakers’ refusal of a bill to create a formal, bipartisan 9/11 Commission-style investigation into the Capitol unrest.
We will talk about Romania, its coronavirus statistics, and what we have to learn from the Romanians. Romania Worldmeter Chart shared that covid-19 cases and deaths have flatlined since May, and maybe you will think that there’s no corona in Romania!
On the “RFK, Jr. The Defender Podcast,” Dr. Peter McCullough discussed a new study by the Oxford University Clinical Research Group and how the Pfizer’s vaccine, at 17% to 42% efficacy, doesn't meet the regulatory standard of 50% efficacy for vaccines.
